Qujia Banmao Su Pian (去甲斑蝥素片)去甲斑蝥素片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司
主要成分Active Ingredients
- 去甲斑蝥素Qujia Banmao Su
药物知识说明
去甲斑蝥素是一种在国家药监局注册认定的药品。该药品含有去甲斑蝥素-32005a2c等成分。
该药品关联的活性成分包括：去甲斑蝥素Qujia Banmao Su。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司。
您可以探索含有相同成分的其他药品：去甲斑蝥素-32005a2c成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 去甲斑蝥素片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 去甲斑蝥素Qujia Banmao Su.
Manufacturers recorded for this product: 山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司.
Explore other medicines containing the same ingredient: 去甲斑蝥素 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 去甲斑蝥素片Recorded Chinese name: 去甲斑蝥素片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 5mg*24片5 mg × 24 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H37023401
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H37023401
Manufacturer
Chinese legal name: 山东信谊制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
5 mg × 24 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H37023401
生产企业
山东信谊制药有限公司(国产)
适应症
用于各种肿瘤如：肝癌、食管癌 、胃癌 ，贲门癌、及白细胞低下症，肝炎、肝硬变、乙型肝炎病毒携带者。亦可作为术前用药或用于联合化疗中。
用法用量
口服。一次5～15mg，一日3次。由小剂量开始逐渐增量，晚期患者可用较高剂量，儿童酌减。疗程为一个月，一般可维持3个疗程。本品可与去甲斑蝥酸纳注射液交替使用。但不宜同时联合用药。
不良反应
部分病人可出现恶心、呕吐、头晕等症状，停药、减量或对症 处理可自行消失。
禁忌
心肾功能不全及孕妇应忌用。
注意事项
1.胃肠道反应有恶心、呕吐。 |2.对泌尿系统有刺激症状，并有阵发性心动过速、手指及面部麻木等。 |3.心肾功能不全及孕妇应忌用。 |4.服药期间要多饮绿茶或开水。
贮藏
遮光，密闭保存。
规格
5mg*24片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.